rs150758981
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_032806.6(POMGNT2):c.421C>T(p.Arg141Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000052 in 1,614,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R141H) has been classified as Likely benign.
Frequency
Consequence
NM_032806.6 missense
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- myopathy caused by variation in POMGNT2Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| POMGNT2 | NM_032806.6 | c.421C>T | p.Arg141Cys | missense_variant | Exon 2 of 2 | ENST00000344697.3 | NP_116195.2 | |
| POMGNT2 | NM_001437285.1 | c.421C>T | p.Arg141Cys | missense_variant | Exon 3 of 3 | NP_001424214.1 | ||
| POMGNT2 | XM_011534163.3 | c.421C>T | p.Arg141Cys | missense_variant | Exon 3 of 3 | XP_011532465.1 | ||
| POMGNT2 | XM_017007353.2 | c.421C>T | p.Arg141Cys | missense_variant | Exon 4 of 4 | XP_016862842.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000657  AC: 10AN: 152238Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.000115  AC: 29AN: 251396 AF XY:  0.000118   show subpopulations 
GnomAD4 exome  AF:  0.0000506  AC: 74AN: 1461878Hom.:  0  Cov.: 37 AF XY:  0.0000481  AC XY: 35AN XY: 727236 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000656  AC: 10AN: 152356Hom.:  0  Cov.: 33 AF XY:  0.0000940  AC XY: 7AN XY: 74504 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases    Uncertain:1 
The c.421C>T (p.R141C) alteration is located in exon 2 (coding exon 1) of the POMGNT2 gene. This alteration results from a C to T substitution at nucleotide position 421, causing the arginine (R) at amino acid position 141 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8    Uncertain:1 
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 141 of the POMGNT2 protein (p.Arg141Cys). This variant is present in population databases (rs150758981, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with POMGNT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 473278). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C55"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at